SCHEMBL17190544

SCHEMBL17190544

CCCCCCCCOc1cc2c3c(cc(OCCCCCCCC)c4c5ccc6c7c(ccc(c1c34)c75)C(=O)N(CCCCC)C6=O)C(=O)N(CCCCC)C2=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STAT3 P40763 1/20 0.46
▸ HIF1A Q16665 1/20 0.46
▸ TERT O14746 7/20 0.45
▸ MEN1 O00255 2/20 0.43
▸ RGS12 O14924 2/20 0.43
▸ HTT P42858 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ PABPC1 P11940 1/20 0.43
▸ RECQL P46063 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ APP P05067 1/20 0.40
▸ BCHE P06276 1/20 0.40
▸ ACHE P22303 1/20 0.40
▸ USP2 O75604 1/20 0.40
▸ POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17190545 0.92 STAT3 (0.47) STAT3HIF1ATERTMEN1RGS12
SCHEMBL17190577 0.91 STAT3 (0.40) STAT3HIF1ATERTMEN1RGS12
SCHEMBL17190564 0.87 STAT3 (0.47) STAT3HIF1ATERTMEN1RGS12
SCHEMBL13784298 0.84 STAT3 (0.49) STAT3HIF1ATERTMEN1RGS12
SCHEMBL17483878 0.83 PPARG (0.35) TERTMAPTCDC25A
SCHEMBL2607401 0.83 STAT3 (0.50) STAT3HIF1ATERTMEN1RGS12
SCHEMBL17483942 0.82 CDC25A (0.36) KDM4EALDH1A1LMNAMAPTNPSR1
SCHEMBL8071104 0.82 STAT3 (0.65) STAT3HIF1ATERTMEN1RGS12
SCHEMBL418871 0.82 STAT3 (0.65) STAT3HIF1ATERTMEN1RGS12
SCHEMBL284967 0.82 STAT3 (0.65) STAT3HIF1ATERTMEN1RGS12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12043782-B2 Liquid crystalline medium MERCK PATENT GMBH (DE) 2024-07-23 — — US disclosed
US-11702597-B2 Azo dye MERCK PATENT GMBH (DE) 2023-07-18 — — US disclosed
US-11667845-B2 Liquid crystalline medium MERCK PATENT GMBH (DE) 2023-06-06 — — US disclosed
US-20180142153-A1 THIADIAZOLOQUINOXALINE DERIVATIVES MERCK PATENT GMBH (DE) 2018-05-24 — — US disclosed
US-20170267929-A1 DEVICE FOR REGULATING THE PASSAGE OF ENERGY MERCK PATENT GMBH (DE) 2017-09-21 — — US disclosed
US-9701905-B2 Liquid-crystalline medium MERCK PATENT GMBH (DE) 2017-07-11 — — US disclosed
US-20160319592-A1 DEVICE FOR REGULATING THE PASSAGE OF LIGHT MERCK PATENT GMBH (DE) 2016-11-03 — — US disclosed
US-20160108317-A1 DEVICE FOR CONTROLLING THE PASSAGE OF ENERGY, CONTAINING A DICHROIC DYE COMPOUND MERCK PATENT GMBH (DE) 2016-04-21 — — US disclosed
US-20160033807-A1 DEVICE FOR REGULATING THE PASSAGE OF ENERGY MERCK PATENT GMBH (DE) 2016-02-04 — — US disclosed
US-20150315473-A1 LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2015-11-05 — — US disclosed
US-20150299577-A1 LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2015-10-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160108317-A1 DEVICE FOR CONTROLLING THE PASSAGE OF ENERGY, CONTAINING A DICHROIC DYE COMPOUND CRY1, SLC25A1, CRY2 STAT3 4607/4885HIF1A 2799/4885TERT 253/4885
US-11667845-B2 Liquid crystalline medium NEFM, CCNI, MYT1 STAT3 936/4885HIF1A 2569/4885TERT 248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback